Diffusion Pharmaceuticals Inc. Profile Avatar - Palmy Investing

Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissue…

Biotechnology
US, Charlottesville [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of DFFN's Analysis
CIK: 1053691 CUSIP: 253748305 ISIN: US15713L1098 LEI: - UEI: -
Secondary Listings
DFFN has no secondary listings inside our databases.